Back to Search
DOUGLAS DRUCKER, PHD
PHD
Psychologist
NPI: 1720175748Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
PSY14138(CA)
Research & Publications (20)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.
PMID 18782641·Lancet·2008
2-rct
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action.
PMID 17337495·Diabetes Care·2007
6-review
Enhancing the action of incretin hormones: a new whey forward?
PMID 16777979·Endocrinology·2006
7-preclinical
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
PMID 17098089·Lancet·2006
6-review
Biologic actions and therapeutic potential of the proglucagon-derived peptides.
PMID 16929363·Nat Clin Pract Endocrinol Metab·2005
6-review
Determination of the dietary habits of a Magdalenian woman from Saint-Germain-la-Rivière in southwestern France using stable isotopes.
PMID 15893359·J Hum Evol·2005
7-preclinical
Does exenatide provide a meaningful new treatment option for patients with type 2 diabetes?
PMID 16929370·Nat Clin Pract Endocrinol Metab·2005
8-other
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis.
PMID 14645210·Endocrinology·2003
6-review
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
PMID 12517256·Expert Opin Investig Drugs·2003
6-review
Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
PMID 12554744·Mol Endocrinol·2003
6-review
Enhancing incretin action for the treatment of type 2 diabetes.
PMID 14514604·Diabetes Care·2003
6-review
Biological actions and therapeutic potential of the glucagon-like peptides.
PMID 11832466·Gastroenterology·2002
6-review
Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.
PMID 11472275·Curr Pharm Des·2001
6-review
New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
PMID 11193827·Ann N Y Acad Sci·2000
6-review
Normalization of obesity-associated insulin resistance through immunotherapy.
PMID 19633657·Nat Med·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16615 LARK AVE, STE 203
LOS GATOS, CA 95032 - Phone
- (408) 358-8792
Quick Facts
- NPI
- 1720175748
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile